SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $36,000 | -16.3% | 10,500 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $43,000 | +22.9% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $35,000 | +45.8% | 10,500 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $24,000 | -63.1% | 10,500 | -41.3% | 0.00% | -57.1% |
| Q4 2019 | $65,000 | -56.1% | 17,900 | 0.0% | 0.01% | -58.8% |
| Q3 2019 | $148,000 | -9.8% | 17,900 | -6.0% | 0.02% | -5.6% |
| Q2 2019 | $164,000 | -19.2% | 19,050 | 0.0% | 0.02% | -21.7% |
| Q1 2019 | $203,000 | +18.0% | 19,050 | -3.1% | 0.02% | 0.0% |
| Q4 2018 | $172,000 | -47.9% | 19,650 | 0.0% | 0.02% | -36.1% |
| Q3 2018 | $330,000 | -19.9% | 19,650 | 0.0% | 0.04% | -25.0% |
| Q2 2018 | $412,000 | +43.1% | 19,650 | +9.8% | 0.05% | +41.2% |
| Q1 2018 | $288,000 | -17.9% | 17,900 | -3.2% | 0.03% | -20.9% |
| Q4 2017 | $351,000 | +34.5% | 18,500 | 0.0% | 0.04% | +26.5% |
| Q3 2017 | $261,000 | +89.1% | 18,500 | 0.0% | 0.03% | +78.9% |
| Q2 2017 | $138,000 | – | 18,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |